Latest Press Release on drugs

New Discount Drug Program Benefits the Growing Unemployed
MedSaverCard, a free program providing discounts on prescription drugs for people without health insurance, wants the growing number of unemployed workers to know they have options when it comes to buying prescription drugs./I/P P(PRWEB) November 23, 2009 -- MedSaverCard, a free program...


Cambridge-based Ligon Discovery Raises $1M in Seed Funding
CAMBRIDGE, Mass., Nov. 19 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced that it has raised $1M in seed financing led by incTANK Ventures. The company will use the capital to co...


AVI BioPharma, Inc. Presents Update on AVI-4658 at TREAT-NMD / NIH International Conference
BOTHELL, WA -- 11/19/09 -- AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced presentations on the company's exon skipping therapy for Duchenne muscular dystrophy at the TREAT-NMD / NIH International Conference taki..


Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
BEIJING, Nov. 24 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescriptions drugs and licensed national seller of pharmaceutical pr...


Single Mom Debuts a Spectacular True Story, No Happily Ever After But...
No Happily Ever After But... is an intriguing story of a woman's life who struggled with alcohol, drugs, anxiety and adversity to an amazing experience that led her to a one of a kind 'rose'. Never has there been a 'rose' like this before. Debbie Fellows never intended to write a book however...


Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman
CAMBRIDGE, Mass., Nov. 23 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced the appointment of pharmaceutical industry veteran Errol B. De Souza as Ligon's Executive Chairman o...


Pharmasset Reports Fiscal Year End 2009 Financial Results
PRINCETON, N.J., Nov. 25 -- Pharmasset, Inc. (Nasdaq: VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported financial results for the fiscal year ended September 30, ...


Rapid drugs of abuse screening from Randox
Randox have developed an innovative multi-marker drugs of abuse testing procedure for rapid drug screening programmes. The Drugs of Abuse (DoA) biochips permit the analysis of up to 10 drug classes from a single patient sample providing rapid and accurate testing.


DopeStats.com Provides Statistical Information on Legal and Illegal Drugs in Each U.S. County
Information about drug use and drug information is now just a click away with the recently launched DopeStats.com. The new site is an online statistical database documenting drug use in more than 3,000 counties in the United States. The data is compiled by anonymous users on drugs and herbs f...


Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve
Despite years of controversy, new study finds that generic drugs to be equally as effective as brand name drugs./I/P P(PRWEB) November 19, 2009 -- A recent publication in the October issue of The Medical Letter may help to eliminate the fear many people have about generic drugs. A syste...


Latest Trend to Lose Weight: Nutritional Body Cleansing
Most of us are exposed to doctors, hospitals and taught to take prescription medication (drugs) to treat the symptoms of the life illnesses and weight loss. Through the use of natural a href= http://www.cleansingandnutrition.com/ onclick= linkClick( this.href ); target= _blank title= bo...


Cardinus Supports Road Safety Week Focus on Drink and Drugs
Cardinus Risk Management is backing this year’s Road Safety Week, which is focusing on the theme of drinks and drugs, and endorsing the message from the organisers, road safety charity Brake, for companies to do more in getting the message across to staff about the dangers of driving un...


FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations
RIDGEFIELD, Conn. & NEW YORK - The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new drug application (sNDA) provide substantial and convincing evidence to support the claim that SPIRIVA





 
 

Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark

 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.